Folakemi Odedina, Doug Murrell, Monica Albertie, Sharon Levey named to community outreach and engagement roles at Mayo Clinic

Mayo Clinic researchers link CAR T-cell aging to cancer relapse

The aging process known as senescence is a mechanism involved in the failure of CAR T-cell therapy, according to a study by researchers at the Mayo Clinic.

July 18, 2025

Vol.51 No.28

Clinical Roundup

Mayo Clinic researchers use biobanking tissue to better characterize ovarian cancer origins

Little is known about what causes ovarian cancer, and there is no way to detect it early. Now, an accidental finding in a 22-year-old patient has given Mayo Clinic researchers a new lead.

June 27, 2025

Vol.51 No.25

Clinical Trials & Tribulations

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Our Hispanic community is a vibrant and essential part of the American tapestry, contributing richly to the country’s society, culture, and economy. Yet, when it comes to healthcare, this community grapples with significant disparities, especially in cancer care.

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Clairity Inc. received FDA De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025—propelling a new era of precision medicine in breast cancer.

June 06, 2025

Vol.51 No.22

Clinical Roundup

Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth

Mayo Clinic researchers have established the world’s first biobank of human salivary gland tissue-organoids to study chronic dry mouth, or xerostomia, an agonizing side effect of damaged salivary glands that affects millions.

May 23, 2025

Vol.51 No.20

Clinical Roundup

Study assesses advancing racial equity in cancer care through multimodal AI

Artera, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, announced the publication of a validation study in the JCO Clinical Cancer Informatics on Artera’s MMAI model.

May 16, 2025

Vol.51 No.19

Folakemi Odedina, Doug Murrell, Monica Albertie, Sharon Levey named to community outreach and engagement roles at Mayo Clinic

YOU MAY BE INTERESTED IN

Mayo Clinic researchers link CAR T-cell aging to cancer relapse

Mayo Clinic researchers use biobanking tissue to better characterize ovarian cancer origins

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth

Study assesses advancing racial equity in cancer care through multimodal AI

Renew today!

Subscriber content

Never miss an issue!

Login